ARKK
RKLB
ARK’s Rocket Lab obsession is back
Cathie Wood’s ARK Invest just went shopping in Rocket Lab again, buying 233,482 shares worth about $16.3 million across ARKK, ARKQ and ARKX. That pushes ARK’s Rocket Lab buying since Sep. 22 to roughly 593,000 shares — more than $41 million total. In other words: this isn’t a little nibble. It’s a recurring vote of confidence.
Why this matters to investors
Rocket Lab isn’t just being treated like a one-off space trade anymore. It’s showing up as a core holding across multiple ARK products, including ARKX where it already makes up about 6.07% of the portfolio. That kind of positioning can matter because ETF flows can become a self-reinforcing loop: strong thesis, more buying, more attention, repeat.
And the business backdrop is doing its part too. Rocket Lab reported record Q2 revenue of $234 million, up 62% year over year, while backlog hit $2.36 billion, up 137% from a year earlier. The company also added more juice to that backlog this week when Synspective agreed to buy 20 more Electron launches scheduled from 2028 through 2031.
The bigger bet is Neutron
The real long-term story is Neutron, Rocket Lab’s reusable medium-lift rocket. If it works, the company could graduate from niche small-launch player to something a lot more ambitious: bigger commercial missions, constellation launches, and even national-security work. That’s the kind of upgrade that can turn a cool space company into a much larger addressable-market story.
ARK did trim Palantir a bit on the same day, but the bigger message is pretty clear: money is moving toward Rocket Lab. For ETF investors, RKLB is increasingly the shiny thing in multiple ARK baskets — not just the space one.
Big picture: ARK is basically saying Rocket Lab may be more than a moonshot. It might be the rocket.